NPI: 1497708929 · MEXIA, TX 76667 · Ambulatory Surgical Clinic/Center · NPI assigned 05/18/2006
Authorized official TRAYLOR, JOHNETTA controls 20+ related entities in our dataset. Read more
| Authorized Official | TRAYLOR, JOHNETTA (ADMIN) |
| NPI Enumeration Date | 05/18/2006 |
Other providers sharing the same authorized official: TRAYLOR, JOHNETTA
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 82 | $8K |
| 2021 | 4,902 | $304K |
| 2022 | 6,969 | $962K |
| 2023 | 6,043 | $759K |
| 2024 | 1,421 | $154K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 3,967 | 3,813 | $1.02M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 1,495 | 1,429 | $791K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 498 | 484 | $91K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,077 | 1,018 | $69K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1,772 | 1,714 | $43K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 124 | 119 | $36K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1,520 | 1,466 | $30K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 200 | 190 | $18K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 156 | 152 | $16K |
| 87070 | 834 | 807 | $15K | |
| 87081 | 897 | 870 | $12K | |
| 87430 | 194 | 191 | $9K | |
| 80053 | Comprehensive metabolic panel | 1,638 | 1,507 | $9K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 115 | 114 | $8K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1,694 | 1,541 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 65 | 63 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 14 | 12 | $1K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 98 | 92 | $920.98 |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13 | 12 | $909.38 |
| 84443 | Thyroid stimulating hormone (TSH) | 182 | 179 | $620.02 |
| 36415 | Collection of venous blood by venipuncture | 1,801 | 1,698 | $609.51 |
| 87420 | 13 | 12 | $452.40 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 12 | 12 | $443.62 |
| 83036 | Hemoglobin; glycosylated (A1C) | 366 | 366 | $382.97 |
| 80061 | Lipid panel | 258 | 257 | $257.04 |
| 81001 | 42 | 41 | $218.69 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 88 | 88 | $150.07 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 14 | 13 | $146.93 |
| 71045 | Radiologic examination, chest; single view | 28 | 26 | $79.76 |
| 84484 | 50 | 36 | $61.70 | |
| 81003 | 92 | 84 | $32.96 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 26 | 24 | $14.19 |
| A9270 | Non-covered item or service | 44 | 38 | $0.00 |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 30 | 30 | $0.00 |